Overview

Observational Follow-up of Participants From Clinical Trial 64,185-202 (NCT00850993)

Status:
Completed
Trial end date:
2015-11-09
Target enrollment:
0
Participant gender:
All
Summary
Observational follow-up of participants from earlier interventional trial 64,185-202 (NCT00850993). No interventions were administered during this follow-up study.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
InfaCare Pharmaceuticals Corporation
InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company
Treatments:
Tin mesoporphyrin
Criteria
Inclusion Criteria:

Participants who received treatment in clinical trial 64,185-202 and for whom informed
consent was given for long term safety followup

Exclusion Criteria:

Participants were excluded by the investigator for medical reasons or by parents/guardians
withdrawing consent